For decades, the opioid crisis has cast a shadow over pain management in the United States. Millions of Americans suffering from chronic pain have faced a difficult choice: enduring persistent discomfort or risking opioid addiction with conventional painkillers. But now, a safe and revolutionary option has emerged: the FDA has just approved Suzetrigine (Journavx) – the first-of-its-kind non-opioid analgesic, providing…